Oxidative damage in immunoglobulin light chain and transthyretin cardiac amyloidosis - a closer look

Abstract

Heart failure is a progressive disease, representing a growing cause of morbidity, hospitalization and mortality. An increasingly common type of heart failure with preserved ejection fraction (HFpEF) is the immunoglobulin light chain and transthyretin cardiac amyloidosis, in the pathophysiology of which oxidative damage appears to exert a strong impact. Reactive oxygen and nitrogen species have physiological signaling functions, but their overaccumulation, as in cardiac amyloidosis, leads to cardiomyocyte damage and apoptosis, and to cardiac hypertrophy and fibrosis. Moreover, such pathological processes worsen the redox damage with the perpetuation of an inflammatory state, in a vicious cycle. Here reviewed are the role of oxidative damage in the transthyretin and immunoglobulin light chain cardiac amyloidosis, the underlying pathogenic mechanisms, the therapeutic implications and possible future strategies.